ational Tick bites study

Completed

• Conditions: Borreliosis; Lyme disease; 10019815

• Registration Number: NL-OMON30529
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1200

Inclusion Criteria

Patiënts with a tick bite, who still have the tick.
Patiënts with an erythema migrans

Exclusion Criteria

Not having a tick bite, a tick or an erythema migrans
Being younger than 6 yrs of age

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- seroconversion of antibodies against Borrelia, by means of comparison of<br /><br>nul-serology with serology after 10 to 12 weeks.<br /><br>- microbiological identification of Borrelia, Ehrlichia, Rickettsia en Babesia<br /><br>in ticks by means of PCR.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- seroconversion of antibodies against Ehrlichia, Rickettsia en Babesia, by<br /><br>means of comparison of nul-serology with serology after 10 to 12 weeks.<br /><br>- microbiological identification of Ehrlichia, Rickettsia en Babesia in blood<br /><br>by means of PCR.</p><br>